Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ARCTURUS THERAPEUTICS HOLDINGS INC.

(ARCT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cantor Fitzgerald Adjusts Price Target on Arcturus Therapeutics Holdings to $93 From $85, Keeps Overweight Rating

11/16/2021 | 10:09am EST


ę MT Newswires 2021
All news about ARCTURUS THERAPEUTICS HOLDINGS INC.
01/11ARCTURUS THERAPEUTICS HOLDINGS INC. : Regulation FD Disclosure (form 8-K)
AQ
2021Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(4)
AQ
2021Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BU
2021Top Midday Gainers
MT
2021Arcturus Therapeutics' COVID-19 Vaccine Candidate Shows Neutralizing Activity in Booste..
MT
2021Arcturus Therapeutics Reports New Data and Provides Additional Updates from ARCT-154 an..
BU
2021Arcturus Therapeutics Reports New Data and Provides Additional Updates from ARCT-154 an..
CI
2021ARCTURUS THERAPEUTICS : Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directo..
PU
2021ARCTURUS THERAPEUTICS HOLDINGS INC. : Change in Directors or Principal Officers, Amendment..
AQ
2021Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Direct..
BU
More news
Analyst Recommendations on ARCTURUS THERAPEUTICS HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2021 21,6 M - -
Net income 2021 -210 M - -
Net cash 2021 306 M - -
P/E ratio 2021 -4,30x
Yield 2021 -
Capitalization 883 M 883 M -
EV / Sales 2021 26,7x
EV / Sales 2022 2,42x
Nbr of Employees 118
Free-Float 86,1%
Chart ARCTURUS THERAPEUTICS HOLDINGS INC.
Duration : Period :
Arcturus Therapeutics Holdings Inc. Technical Analysis Chart | ARCT | US03969T1097 | MarketScreener
Technical analysis trends ARCTURUS THERAPEUTICS HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 33,48 $
Average target price 85,45 $
Spread / Average Target 155%
EPS Revisions
Managers and Directors
Joseph E. Payne President, Chief Executive Officer & Director
Andrew H. Sassine Chief Financial Officer & Director
Peter C. Farrell Chairman
Padmanabh Chivukula Secretary, Chief Operating & Scientific Officer
Steven G. Hughes Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
ARCTURUS THERAPEUTICS HOLDINGS INC.-9.54%883
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%52 584
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684